BIIB Apr 2023 265.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:08PM EDT. Market open.
Loading interactive chart…
- Zacks
Ionis (IONS) Posts New Upbeat Data From Amyloidosis Drug Study
Ionis (IONS) reports positive long-term phase III study data, supporting the benefits of eplontersen as a treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).
- Simply Wall St.
Biogen Inc. (NASDAQ:BIIB) is a favorite amongst institutional investors who own 88%
Key Insights Given the large stake in the stock by institutions, Biogen's stock price might be vulnerable to their...
- Zacks
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval
Incyte's (INCY) skin cancer drug approval and Altimmune's obesity data are the key highlights from the biotech sector during the past week.
© 2023 Yahoo. All rights reserved.
